Detalhe da pesquisa
1.
The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects.
Hum Mol Genet
; 31(8): 1293-1307, 2022 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726235
2.
ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity.
JCI Insight
; 8(2)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480289
3.
Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB/NJ-Ighmpb2 nmd-2J.
Mol Ther Methods Clin Dev
; 23: 23-32, 2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34553000